Literature DB >> 24797049

Hyperhomocysteinaemia, low folate concentrations and MTHFR C677T mutation in abdominal aortic aneurysm.

Hui Cao1, Xinhua Hu1, Qiang Zhang1, Jun Li1, Bing Liu1, Junpeng Wang1, Yang Shao1, Zhishen Zhang2, Chengwei Liu3, Haidi Hu1, Jian Zhang1, Shijie Xin1.   

Abstract

BACKGROUND: Homocysteine (Hcy) has been implicated in abdominal aortic aneurysm (AAA). However, the association of Hcy, vitamin B12, and folate in patients with AAA has not been studied in China. This study was conducted with the aim to evaluate the relationship of vitamin B12, folic acid, and Hcy levels in AAA. PATIENTS AND METHODS: 463 patients who had AAA were included in this study. 463 control subjects were age- and sex-matched with the patients. In all of the subjects, we evaluated total plasma levels Hcy, vitamin B12, folic acid and the distribution of the C677T methylenetetrahydrofolate reductase (MTHFR) gene mutation.
RESULTS: The mean plasma Hcy levels were significantly higher in patients with AAA compared with controls (18.37 ± 6.97 vs. 12.89 ± 4.08 μmol/L, P < 0.001). The frequency of homozygous (TT) genotype in MTHFR C677T mutation was significantly higher in patients with AAA than that in control subjects (19.4 % vs. 11.9 %, P = 0.002). The fasting Hcy correlated negatively with folate (AAA: r = - 0.311, P < 0.01; CONTROL: r = - 0.348, P < 0.01). The aneurysm size was significantly greater (P < 0.001) in patients with hyperhomocysteinemia than that in patients with normal Hcy plasma levels. The size of the AAA had a linear correlation with the plasma Hcy level (r = 0.286; P< 0.001).
CONCLUSIONS: Serum folate deficiency and hyperhomocysteinemia were associated with an increased risk of AAA in Northeast China. The homozygous (TT) genotype of MTHFR gene mutation may be a crucial hereditary risk factor in AAA.

Entities:  

Keywords:  Homocysteine; abdominal aortic aneurysm; folate; methylene tetrahydrofolate reductase; vitamin B12

Mesh:

Substances:

Year:  2014        PMID: 24797049     DOI: 10.1024/0301-1526/a000347

Source DB:  PubMed          Journal:  Vasa        ISSN: 0301-1526            Impact factor:   1.961


  5 in total

1.  Hyperhomocysteinemia as a metabolic disorder parameter is independently associated with the severity of coronary heart disease.

Authors:  Chenggui Liu; Yinzhong Yang; Duanliang Peng; Linong Chen; Jun Luo
Journal:  Saudi Med J       Date:  2015-07       Impact factor: 1.484

Review 2.  Association between MTHFR C677T polymorphism and abdominal aortic aneurysm risk: A comprehensive meta-analysis with 10,123 participants involved.

Authors:  Jie Liu; Xin Jia; Haifeng Li; Senhao Jia; Minhong Zhang; Yongle Xu; Xin Du; Nianrong Zhang; Weihang Lu; Wei Guo
Journal:  Medicine (Baltimore)       Date:  2016-09       Impact factor: 1.889

3.  Hyperhomocysteinaemia is an independent risk factor of abdominal aortic aneurysm in a Chinese Han population.

Authors:  Jie Liu; Shang Wei Zuo; Yue Li; Xin Jia; Sen Hao Jia; Tao Zhang; Yu Xiang Song; Ying Qi Wei; Jiang Xiong; Yong Hua Hu; Wei Guo
Journal:  Sci Rep       Date:  2016-02-11       Impact factor: 4.379

Review 4.  Genetic and Epigenetic Regulation of Aortic Aneurysms.

Authors:  Ha Won Kim; Brian K Stansfield
Journal:  Biomed Res Int       Date:  2017-01-01       Impact factor: 3.411

5.  The Prevalence of Hypertension Accompanied by High Homocysteine and its Risk Factors in a Rural Population: A Cross-Sectional Study from Northeast China.

Authors:  Ye Chang; Yuan Li; Xiaofan Guo; Yintao Chen; Dongxue Dai; Yingxian Sun
Journal:  Int J Environ Res Public Health       Date:  2017-04-03       Impact factor: 3.390

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.